Fig. 1.
A graphic showing the treatment of patients and their antidiabetic medication. SGLT2-I, sodium-glucose cotransporter type 2 inhibitors; DPP4-I, dipeptidyl peptidase-4 inhibitor; GLP-1, glucagon-like peptide-1.
A graphic showing the treatment of patients and their antidiabetic medication. SGLT2-I, sodium-glucose cotransporter type 2 inhibitors; DPP4-I, dipeptidyl peptidase-4 inhibitor; GLP-1, glucagon-like peptide-1.
